Abstract
Improvements in prostate MR imaging techniques and the introduction of MR imaging-targeted biopsies have had central roles in prostate cancer (PCa) management. The role of MR imaging has progressed from largely staging patients with biopsy-proven PCa to detecting, characterizing, and guiding the biopsy of suspected PCa. These diagnostic advances, combined with improved therapeutic interventions, have led to a more sophisticated and individually tailored approach to patients’ unique PCa profile. This review discusses the MR imaging, a standardized reporting scheme, and the role of fusion-targeted prostate biopsy.
Original language | English (US) |
---|---|
Pages (from-to) | 303-320 |
Number of pages | 18 |
Journal | Radiologic Clinics of North America |
Volume | 55 |
Issue number | 2 |
DOIs | |
State | Published - Mar 1 2017 |
Keywords
- Diffusion-weighted imaging
- MR imaging
- PI-RADS
- Prostate biopsy
- Prostate cancer
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging